HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG ...
The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia.
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, ...
Interpreting relatively inexpensive electrocardiograms (ECGs) with an artificial intelligence (AI) algorithm accurately ...
A pulmonary embolism (PE) is a blood clot in one of the arteries in the lungs. It not only blocks blood flow in the lungs, but it can affect heart function by making the right side of the heart work ...
Rhythm (Nasdaq:IRTC) today announced findings from two real-world analyses supporting its long-term heart monitoring technology.
A research team led by Prof. Jerald Yoo from the Department of Electrical and Computer Engineering at Seoul National ...